Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
diagnostic tests
MedTech
OraSure sees investor pressure, potential proxy fight: report
Infectious disease testmaker OraSure may have a fight brewing over its board of directors following the recent rejection of a buyout offer.
Conor Hale
Sep 9, 2025 12:00pm
FDA formally kicks off medical device user fee negotiations
Aug 4, 2025 4:45pm
The highest-paid medtech CEOs of 2024
Jul 28, 2025 6:00am
BD biosciences, diagnostics units move to Waters in $17.5B deal
Jul 14, 2025 11:09am
Caris Life Sciences ups IPO to raise $494M
Jun 18, 2025 11:00am
Inside Fierce Medtech's Fierce 15
Jun 13, 2025 8:47am
